Stay updated on Pimavanserin in Impulse Control Disorders Clinical Trial
Sign up to get notified when there's something new on the Pimavanserin in Impulse Control Disorders Clinical Trial page.

Latest updates to the Pimavanserin in Impulse Control Disorders Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 to the history log and removed the older v3.4.1 notice along with the government funding/operating status notice.SummaryDifference0.7%

- Check21 days agoChange DetectedA site-wide funding notice was added and the version history shows Revision: v3.4.1 (replacing v3.4.0); these are administrative and do not modify study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check28 days agoChange DetectedThe study history view now shows a glossary toggle, green highlights for additions and red highlights for deletions, and explicit revision labeling (v3.4.0), improving readability of version histories. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check42 days agoChange DetectedThe page history shows a new revision entry (Revision: v3.3.4) and removal of Revision: v3.3.3, which are minor metadata updates to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page history shows an addition of Revision: v3.3.3 and deletions of HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer area. These are site-wide updates and do not affect the study record, data, or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedAdded revision v3.3.2 to the record history and removed revision v3.2.0.SummaryDifference0.1%

Stay in the know with updates to Pimavanserin in Impulse Control Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pimavanserin in Impulse Control Disorders Clinical Trial page.